Scientists from Russia using modified cells contained in the umbilical
New study offers hope for patients suffering from a rare form of blindness
A new form of therapy may halt or even reverse
Appendix identified as a potential starting point for Parkinson’s disease
Removing the appendix early in life reduces the risk of
Parkinson’s treatment: Medication, therapy, alternative remedies
Treatment approaches include medication, surgery, alternative and complementary therapies, occupational
Scientists have voiced one of the main reasons for the development of dementia
Most cases of developing dementia may not be associated with
New transgenic model of Parkinson’s illuminates disease biology
Parkinson’s disease (PD) is a neurodegenerative disorder that presents clinically
Scientists get the drop on the cell’s nucleus: New method offers potential means for detection of disease
A team of physicists has devised a novel strategy that
Disease causing mutation found in French-Canadians: Carriers at higher risk of developing neurodegenerative disease
A team of Canadian scientists, including researchers at the Montreal
FDA Issues Statement Reaffirming the Positive Benefit-Risk Profile of Nuplazid (pimavanserin) for Patients with Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis
SAN DIEGO–(BUSINESS WIRE)–Sep. 20, 2018– Acadia Pharmaceuticals Inc. (NASDAQ: ACAD)
How the immune system protects against Zika-induced neurological symptoms
A type of immune cell that produces a protein called